Viewing Study NCT01535950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT01535950
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2012-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-elated Macular Degeneration (Wet AMD) View
None Exudative Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age-related macular degeneration View
None intravitreal, neovascular View
None anti-vascular endothelial growth factor View
None wet AMD View
None Age-related View
None Macular degeneration View
None Intravitreal View
None Neovascular View